Found: 40
Select item for more details and to access through your institution.
Finding a Human Leukocyte Antigen Match -- A Perfect Stranger.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 8, p. 2160, doi. 10.3390/pharmaceutics15082160
- By:
- Publication type:
- Article
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 4, p. 614, doi. 10.3390/ph16040614
- By:
- Publication type:
- Article
Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients' Voice or a Missed Opportunity
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 2, p. E158, doi. 10.1016/j.clgc.2021.12.002
- By:
- Publication type:
- Article
Balancing clinical evidence in the context of a pandemic.
- Published in:
- 2021
- By:
- Publication type:
- Letter
A phase i study of ixazomib and erlotinib in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 99, doi. 10.1007/s10637-021-01153-y
- By:
- Publication type:
- Article
First-line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell Carcinoma: Where Are We Going, Where Have We Been?
- Published in:
- Drugs, 2022, v. 82, n. 4, p. 439, doi. 10.1007/s40265-022-01683-6
- By:
- Publication type:
- Article
Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis.
- Published in:
- NPJ Genomic Medicine, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41525-022-00346-5
- By:
- Publication type:
- Article
Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the 'NSCLC' of GI Oncology?
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1578, doi. 10.3390/cancers15051578
- By:
- Publication type:
- Article
Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3600, doi. 10.3390/cancers13143600
- By:
- Publication type:
- Article
Cancer Genetics and Therapeutic Opportunities in Urologic Practice.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 710, doi. 10.3390/cancers12030710
- By:
- Publication type:
- Article
Adjuvant Treatment in Renal Cell Carcinoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, p. 555
- By:
- Publication type:
- Article
Multi‐omic analysis in carcinoma of unknown primary (CUP): therapeutic impact of knowing the unknown.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 956, doi. 10.1002/1878-0261.13293
- By:
- Publication type:
- Article
Multi‐omic analysis in carcinoma of unknown primary (CUP): therapeutic impact of knowing the unknown.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 956, doi. 10.1002/1878-0261.13293
- By:
- Publication type:
- Article
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00701-y
- By:
- Publication type:
- Article
Pan-cancer analysis of TIM-3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 1, p. 1, doi. 10.1002/cam4.6844
- By:
- Publication type:
- Article
LAG‐3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 12, p. 13155, doi. 10.1002/cam4.6000
- By:
- Publication type:
- Article
On target methods to induce abscopal phenomenon for Off‐Target effects: From happenstance to happenings.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 6451, doi. 10.1002/cam4.5454
- By:
- Publication type:
- Article
Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.627025
- By:
- Publication type:
- Article
Incomplete Resolution of Deep Vein Thromboses during Rivaroxaban Therapy.
- Published in:
- Case Reports in Cardiology, 2017, p. 1, doi. 10.1155/2017/3628127
- By:
- Publication type:
- Article
When Herd Immunity Is the Only Protection.
- Published in:
- American Journal of Public Health, 2016, v. 106, n. 6, p. 965, doi. 10.2105/AJPH.2016.303150
- By:
- Publication type:
- Article
Translating Knowledge About the Immune Microenvironment of Gastrointestinal Stromal Tumors into Effective Clinical Strategies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Incontinentia Pigmenti with Persistent Hypercalcemia: Case Report.
- Published in:
- Pediatric Dermatology, 2016, v. 33, n. 5, p. e315, doi. 10.1111/pde.12925
- By:
- Publication type:
- Article
Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma.
- Published in:
- Case Reports in Oncology, 2018, v. 11, n. 2, p. 276, doi. 10.1159/000489995
- By:
- Publication type:
- Article
Home-run trials for rare cancers: giving the right drug(s) to the right patients at the right time and in the right place.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00487-5
- By:
- Publication type:
- Article
Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00378-9
- By:
- Publication type:
- Article
Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 16, p. 2505, doi. 10.3390/cells11162505
- By:
- Publication type:
- Article
Clinical Development of PARP Inhibitors in Treating Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 8, p. 860, doi. 10.3390/cells8080860
- By:
- Publication type:
- Article
A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 94, doi. 10.1634/theoncologist.2019-0636
- By:
- Publication type:
- Article
Artificial Intelligence Systems Assisting Oncologists? Resist and Desist or Enlist and Coexist.
- Published in:
- Oncologist, 2019, v. 24, n. 10, p. 1291, doi. 10.1634/theoncologist.2019-0267
- By:
- Publication type:
- Article
If Walls Could Talk.
- Published in:
- Oncologist, 2019, v. 24, n. 5, p. 720, doi. 10.1634/theoncologist.2019-0111
- By:
- Publication type:
- Article
Inside Out.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 868, doi. 10.1634/theoncologist.2016-0002
- By:
- Publication type:
- Article
Click, Click.
- Published in:
- Oncologist, 2016, v. 21, n. 1, p. 127, doi. 10.1634/theoncologist.2015-0318
- By:
- Publication type:
- Article
Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Therapeutic Implications of Epidermal Growth Factor Receptor (EGFR) in the Treatment of Metastatic Gastric/GEJ Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01312
- By:
- Publication type:
- Article
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18613-3
- By:
- Publication type:
- Article
The paradox of cancer genes in non-malignant conditions: implications for precision medicine.
- Published in:
- Genome Medicine, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13073-020-0714-y
- By:
- Publication type:
- Article
Genomics and Immunomics in the Treatment of Urothelial Carcinoma.
- Published in:
- Current Oncology, 2022, v. 29, n. 5, p. 3499, doi. 10.3390/curroncol29050283
- By:
- Publication type:
- Article
Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03293-3
- By:
- Publication type:
- Article